Home Other Building Blocks (S)-4-Aminohex-5-enoic acid

(S)-4-Aminohex-5-enoic acid

CAS No.:
74046-07-4
Catalog Number:
AG00FDS4
Molecular Formula:
C6H11NO2
Molecular Weight:
129.1570
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
250mg
95%
1 week
United States
$673
- +
1g
95%
1 week
United States
$1625
- +
Product Description
Catalog Number:
AG00FDS4
Chemical Name:
(S)-4-Aminohex-5-enoic acid
CAS Number:
74046-07-4
Molecular Formula:
C6H11NO2
Molecular Weight:
129.1570
MDL Number:
MFCD00274076
IUPAC Name:
(4S)-4-aminohex-5-enoic acid
InChI:
InChI=1S/C6H11NO2/c1-2-5(7)3-4-6(8)9/h2,5H,1,3-4,7H2,(H,8,9)/t5-/m1/s1
InChI Key:
PJDFLNIOAUIZSL-RXMQYKEDSA-N
SMILES:
N[C@H](C=C)CCC(=O)O
UNII:
0S931RNJ68
Properties
Complexity:
112  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
129.079g/mol
Formal Charge:
0
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
129.159g/mol
Monoisotopic Mass:
129.079g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
63.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-2.2  
Literature
Title Journal
Epilepsy in Korean patients with Angelman syndrome. Korean journal of pediatrics 20120501
[11C]flumazenil binding is increased in a dose-dependent manner with tiagabine-induced elevations in GABA levels. PloS one 20120101
Transition to absence seizures and the role of GABA(A) receptors. Epilepsy research 20111201
Experimental panic provocation in healthy man-a translational role in anti-panic drug development? Dialogues in clinical neuroscience 20111201
Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments. Addiction science & clinical practice 20110701
Effects of GABA-transaminase inhibitor Vigabatrin on thermoregulation in rats. Amino acids 20110501
Repeated administration of the GABAB receptor positive modulator BHF177 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine seeking in rats. Psychopharmacology 20110501
Depressogenic effects of medications: a review. Dialogues in clinical neuroscience 20110301
[West syndrome: aetiology, therapeutic options, clinical course and prognostic factors]. Revista de neurologia 20110116
Oral Administration of Semicarbazide Limits Weight Gain together with Inhibition of Fat Deposition and of Primary Amine Oxidase Activity in Adipose Tissue. Journal of obesity 20110101
Severe myoclonic epilepsy of infancy (Dravet syndrome): Clinical and genetic features of nine Turkish patients. Annals of Indian Academy of Neurology 20110101
[Antiepileptic drug-induced encephalopathy]. Fortschritte der Neurologie-Psychiatrie 20101001
Genoa syndrome and central diabetes insipidus: a case report. Journal of clinical research in pediatric endocrinology 20100601
Gamma-vinyl GABA increases nonvesicular release of GABA and glutamate in the nucleus accumbens in rats via action on anion channels and GABA transporters. Psychopharmacology 20100301
Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms. Neuropsychiatric disease and treatment 20100101
Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs. BMC clinical pharmacology 20090101
Gamma-vinyl GABA inhibits cocaine-triggered reinstatement of drug-seeking behavior in rats by a non-dopaminergic mechanism. Drug and alcohol dependence 20081001
The search for medications to treat stimulant dependence. Addiction science & clinical practice 20080601
Response: anticipating new medications. Addiction science & clinical practice 20080601
Subchronic treatment with antiepileptic drugs modifies pentylenetetrazol-induced seizures in mice: Its correlation with benzodiazepine receptor binding. Neuropsychiatric disease and treatment 20080601
The effectiveness of anticonvulsants in psychiatric disorders. Dialogues in clinical neuroscience 20080301
GABA(A) receptors in normal development and seizures: friends or foes? Current neuropharmacology 20080301
Neonatal DSP-4 treatment modifies GABAergic neurotransmission in the prefrontal cortex of adult rats. Neurotoxicity research 20080101
Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary. Theoretical biology & medical modelling 20080101
[Endocrine effects of antiepileptic drugs]. Przeglad lekarski 20080101
Imaging the addicted human brain. Science & practice perspectives 20070401
Glucose inhibits GABA release by pancreatic beta-cells through an increase in GABA shunt activity. American journal of physiology. Endocrinology and metabolism 20060301
Demonstration of extensive GABA synthesis in the small population of GAD positive neurons in cerebellar cultures by the use of pharmacological tools. Neurochemistry international 20060101
Structural brain abnormalities in juvenile myoclonic epilepsy patients: volumetry and voxel-based morphometry. Korean journal of radiology 20060101
Alteration of thyroid hormone homeostasis by antiepileptic drugs in humans: involvement of glucuronosyltransferase induction. European journal of clinical pharmacology 20051201
GABAergic modulation of the expression of genes involved in GABA synaptic transmission and stress in the hypothalamus and telencephalon of the female goldfish (Carassius auratus). Journal of neuroendocrinology 20050501
Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction. Synapse (New York, N.Y.) 20050201
Catecholamine depletion modulates serum LH levels, GAD67 mRNA, and GABA synthesis in the goldfish. General and comparative endocrinology 20050201
New anticonvulsant agents. Current topics in medicinal chemistry 20050101
Gamma-vinyl GABA (vigabatrin) blocks the expression of toluene-induced conditioned place preference (CPP). Synapse (New York, N.Y.) 20041201
Increased GAD67 mRNA levels are correlated with in vivo GABA synthesis in the MPTP-treated catecholamine-depleted goldfish brain. Brain research. Molecular brain research 20040928
Synthesis of cyclopropane isosteres of the antiepilepsy drug vigabatrin and evaluation of their inhibition of GABA aminotransferase. Journal of enzyme inhibition and medicinal chemistry 20040801
Opiate tolerance by heroin self-administration: an fMRI study in rat. Magnetic resonance in medicine 20040701
Design, synthesis and anticonvulsive activity of analogs of gamma-vinyl GABA. Farmaco (Societa chimica italiana : 1989) 20040501
Adverse effects of new antiepileptic drugs. Drugs of today (Barcelona, Spain : 1998) 20040401
[Drug interactions with antiepileptic agents]. Wiener klinische Wochenschrift 20040227
Positron emission tomography studies of potential mechanisms underlying phencyclidine-induced alterations in striatal dopamine. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20031201
Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA. Synapse (New York, N.Y.) 20031201
Enhancement of neuronal protection from oxidative stress by glutamic acid decarboxylase delivery with a defective herpes simplex virus vector. Experimental neurology 20031101
Design, synthesis and anticonvulsive activities of potential prodrugs linked by two-carbon chain. Archives of pharmacal research 20031001
[West's syndrome. Analysis, aetiological factors and therapeutic options]. Revista de neurologia 20030801
Kinetic studies on the inhibition of GABA-T by gamma-vinyl GABA and taurine. Journal of enzyme inhibition and medicinal chemistry 20030801
Sub-chronic low dose gamma-vinyl GABA (vigabatrin) inhibits cocaine-induced increases in nucleus accumbens dopamine. Psychopharmacology 20030701
Gamma-vinyl GABA, an irreversible inhibitor of GABA transaminase, alters the acquisition and expression of cocaine-induced sensitization in male rats. Synapse (New York, N.Y.) 20021215
Symptomatic epilepsy associated with intracranial calcifications in children with acute lymphoblastic leukemia (ALL). Collegium antropologicum 20021201
GABAergic mechanisms of heroin-induced brain activation assessed with functional MRI. Magnetic resonance in medicine 20021101
Increased GABA neurotransmission via administration of gamma-vinyl GABA decreased nicotine self-administration in the rat. Synapse (New York, N.Y.) 20020615
The effect of water temperature on the GABAergic and reproductive systems in female and male goldfish (Carassius auratus). General and comparative endocrinology 20020201
Anticonvulsants: aspects of their mechanisms of action. European journal of pain (London, England) 20020101
Gamma vinyl-GABA differentially modulates NMDA antagonist-induced increases in mesocortical versus mesolimbic DA transmission. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20011101
[Microcephaly, bilateral corneal opacity and congenital lobar holoprosencephaly with subsequent development of a rhabdomyosarcoma in a patient exposed to prenatal radiation]. Revista de neurologia 20011101
Gamma-vinyl GABA (GVG) blocks expression of the conditioned place preference response to heroin in rats. Synapse (New York, N.Y.) 20010901
Paradoxical reduction of synaptic inhibition by vigabatrin. Journal of neurophysiology 20010801
Gamma-vinyl GABA reduces paired pulse inhibition in the rat dentate gyrus in vivo and in vitro. Epilepsy research 20010501
GABA transaminase inhibition induces spontaneous and enhances depolarization-evoked GABA efflux via reversal of the GABA transporter. The Journal of neuroscience : the official journal of the Society for Neuroscience 20010415
Properties